BAOTOU , January 30 , SinoCast -- Baotou Dongbao Bio-tech Co., Ltd. (SZSE: 300239) predicted net profit attributable to shareholders between CNY 39 million and CNY 43.5 million in 2013, rising 10.22% to 22.94% from a year earlier, because Beijing subsidiary is still in prophase development and needs great input, and gelatin prices sharply drop down, the performance of the subsidiary is worse then expectation. Hence, Baotou Dongbao will speed up cooperation with US companies to boost collagen exports to overturn dim situation.
Most Popular Stories
- Snowden Among Potential Pulitzer Prize Winners
- Nevada Rancher Discusses BLM Beef With Glenn Beck
- Grand Jury Seated in Rick Perry Ethics Case
- Miami Attorney Being Honored for Charity Work
- India Recognizes Transgender People as 'Third Gender'
- What You Need to Know About Tax Day
- Pay TV Subscriptions Expected to Rise
- Boehner Mocked for 'Electile Dysfunction'
- U.S. Consumer Prices Rose Slightly in March
- Facebook Plans Mobile Payment Service